How to assess early rheumatoid arthritis in daily clinical practice

Best Practice and Research: Clinical Rheumatology

Volumn 19, Issue 1, 2005, Pages 73-89

  Soubrier, Martin ^a   Dougados, Maxime ^b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Assessment; Daily clinical practice; Disability; Early rheumatoid arthritis; Prognostic factors

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; CHLOROQUINE; CITRULLINE; ETANERCEPT; GOLD; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN M; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DIAGNOSTIC VALUE; DISABILITY; DISEASE ACTIVITY; DISEASE DURATION; DRUG RESPONSE; EARLY DIAGNOSIS; ECHOGRAPHY; FOLLOW UP; FUNCTIONAL ASSESSMENT; GOLD THERAPY; HUMAN; JOINT DESTRUCTION; JOINT RADIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; EARLY DIAGNOSIS; HUMANS; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 10844277273     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2004.08.004     Document Type: Review

References (98)

1. D.L. Scott C. Smith G. Kingsley Joint damage and disability in rheumatoid arthritis: An updated systematic review Clin Exp Rheumatol 21 supplement 31 2003 S20-S27
2. P.M. Welsing A.M. van Gestel H.L. Swinkels et al. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis Arthritis Rheum 44 2001 2009-2017
3. M. Drossaers-Bakker D. de Buck D. van Zeben et al. Long-term course and outcome of functional capacity in rheumatoid arthritis: The effect of disease activity and radiologic damage over time Arthritis Rheum 42 1999 1854-1860
4. F. Wolfe A reappraisal of HAQ disability in rheumatoid arthritis Arthritis Rheum 43 2000 2751-2761
5. E.T. Molenaar A.E. Voskuyl B.A. Dijkmans Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission J Rheumatol 29 2002 267-270
6. B.J. Harrison D.P. Symmons Early inflammatory polyarthritis: Results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years Rheumatology (Oxford) 39 2000 939-949
7. K.P. Machold T.A. Stamm G.J.M. Eberl et al. Very recent onset arthritis-clinical, laboratory and radiological findings during the first year of disease J Rheumatol 29 2002 2278-2287
8. D.M. van der Heijde Joint erosions and patients with early rheumatoid arthritis Br J Rheumatol 34 supplement 2 1995 74-78
9. D.L. Scott The diagnosis and prognosis of early arthritis: Rationale for new prognostic criteria Arthritis Rheum 46 2002 286-290
10. H.M. Hulsmans J.W. Jacobs D.M. van der Heijde et al. The course of radiologic damage during the first six years of rheumatoid arthritis Arthritis Rheum 43 2000 1927-1940
11. E. Lindqvist K. Jonsson T. Saxne et al. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis Ann Rheum Dis 62 2003 611-616
12. N.A. Graudal A.J. Jurik A. de Carvalho et al. Radiographic progression in rheumatoid arthritis: A long term prospective study of 109 patients Arthritis Rheum 41 1998 1470-1480
13. M.J. Plant P.W. Jones J. Saklatvala et al. Patterns of radiological progression in early rheumatoid arthritis: Results of an 8 year prospective study J Rheumatol 25 1998 417-426
14. M. Bukhari M. Lunt B.J. Harrison D.G.I. Scott et al. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis. Results from the Norfolk Arthritis Register Study, a large inception cohort Arthritis Rheum 46 2002 906-912
15. B. Combe M. Dougados P. Goupille et al. Prognostc factors for radiographic damage in early rheumatoid arthritis. A multiparameter prospective study Arthritis Rheum 44 2001 1736-1743
16. J.J. Goronzy E.L. Matteson J.W. Fulbright et al. Prognostic markers of radiographic progression in early rheumatoid arthritis Arthritis Rheum 50 2004 43-54
17. T. Möttönen L. Paimela M. Leirisalo-Repo et al. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth"; strategy Ann Rheum Dis 57 1998 533-539
18. L.M.A. Jansen D.V. Van Schaardenburg E. Van der Horst-Bruisna et al. The predictive value of anti-cyclic citrullinated antibodies in early arthritis J Rheumatol 30 2003 1691-1695
19. E.J.J.A. Kroot B.A.W. de Jong M.A. van Leeuwen et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis Arthritis Rheum 43 2000 1831-1835
20. O. Meyer C. Labarre M. Dougados et al. Anticitrullinated protein/peptide antibody essays in early rheumatoid arthritis for predicting five year radiographic damage Ann Rheum Dis 62 2003 120-126
21. J. Vencovsky S. Machacek L. Sedova et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis Ann Rheum Dis 62 2003 427-430
22. J.D. Gorman R.F. Lum J.J. Chen et al. Impact of shared epitope genotype and ethnicity on erosive disease. A meta-analysis of 3,240 rheumatoid arthritis patients Arthritis Rheum 50 2004 400-412
23. P.T. Dawes P.D. Fowler S. Clarke et al. Rheumatoid arthritis: Treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression Br J Rheumatol 25 1986 44-49
24. M.A. van Leeuwen M.H. van Rijswijk W.J. Sluiter et al. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system J Rheumatol 24 1997 20-27
25. H. Visser S. le Cessie F.C. Breedveld et al. How to diagnose rheumatoid arthritis early Arthritis Rheum 46 2002 357-365
26. D. Mulherin O. Fitzgerald B. Bresnihan Clinical improvement and radiological deterioration in rheumatoid arthritis: Evidence that the pathogenesis of inflammation and articular erosion may differ Br J Rheumatol 36 1997 225-228
27. F.M. McQueen N. Stewart J. Crabbe et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement Ann Rheum Dis 58 1999 156-163
28. E.T. Molenaar A.E. Voskuyl H.J. Dinant et al. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission Arthritis Rheum 50 2004 36-42
29. J.R. Kirwan Systemic low-dose glucocorticoid treatment in rheumatoid arthritis Rheum Dis Clin North Am 27 2001 389-403
30. M. Boers P.J. Kostense A.C. Verhoeven et al. Inflammation and damage in an individual joint predict futher damage in that joint in patients with early rheumatoid arthritis Arthritis Rheum 44 2001 2242-2246
31. H.E. Paulus M. Oh J.T. Sharp et al. Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis J Rheum 30 2003 705-713
32. R.J. Wakefield K.O. Kong P.G. Conaghan et al. The role of ultrasonography and magnetic resonance imaging in early rheumatoid arthritis Clin Exp Rheumatol 21 supplement 31 2003 S42-S49
33. F.M. McQueen N. Benton D. Perry et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis Arthritis Rheum 48 2003 1718-1827
34. R.J. Wakefield W.W. Gibbon P.G. Conaghan et al. The value of sonography in the detection of bone erosion in patients with rheumatoid arthritis. A comparison with conventional radiography Arthritis Rheum 43 2000 2762-2770
35. C. Egsmose B. Lund G. Borg et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year follow-up of a prospective double blind placebo controlled study J Rheumatol 22 1995 2208-2213
36. J. Van Aken S.R. Lard S. Le Cessie et al. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis Ann Rheum Dis 63 2004 274-279
37. S.M.M. Verstappen J.W.G. Jacobs J.W.J. Bijlsma et al. Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus active treatment according to the pyramid approach in the first year Arthritis Rheum 48 2003 1797-1807
38. T. Möttönen P. Hannonen M. Korpela et al. Delay to institution therapy and induction of remission using single drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis Arthritis Rheum 46 2002 894-898
39. T. Mottonen P. Hannonen M. Leirisalo-Repo et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial. FIN-RACo trial group Lancet 353 1999 1568-1573
40. M. Boers A.C. Verhoeven H.M. Markusse et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis Lancet 350 1997 309-318
41. R.B. Landewe M. Boers A.C. Verhoeven et al. COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention Arthritis Rheum 46 2002 347-356
42. M.C. Genovese J.M. Bathon R.W. Martin et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis. Two-year radiographic and clinical outcomes Arthritis Rheum 46 2002 1433-1450
43. F.C. Bredveld P. Emery E. Keystone et al. Infliximab in active early rheumatoid arthritis Ann Rheum Dis 63 2004 149-155
44. T.W.J. Huizinga K.P. Machold F.C. Breedveld et al. Criteria for early rheumatoid arthritis. From Bayes' law revisited to new thoughts on pathogenesis Arthritis Rheum 46 2002 1155-1159
45. B.J. Harrison D.P.M. Symmons E.M. Barrett The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis J Rheumatol 25 1998 2324-2330
46. N. Wiles D.P.M. Symmons B. Harrison et al. Estimating the incidence of rheumatoid arthritis. Trying to hit a moving target? Arthritis Rheum 42 1999 1339-1346
47. F.A. Van Gaalen S.P. Linn-Rasker W.J. van Venrooij et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with rheumatoid arthritis Arthritis Rheum 50 2004 709-715
48. W. Grassi E. Filippuci A. Farina et al. Ultrasonography in the evaluation of bone erosions Ann Rheum Dis 60 2001 98-103
49. R. Klocke D. Glew N. Cox et al. Sonographic erosions of the rheumatoid little toe Ann Rheum Dis 60 2001 896
50. R.J. Wakefield M.J. Green H. Marzo-Ortega et al. Should oligoarthritis be reclassified? Ultrasounds reveals a high prevalence of subclinical disease Ann Rheum Dis 63 2004 382-385
51. D.T. Felson J.J. Anderson M. Boers et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials Arthritis Rheum 36 1993 729-740
52. D.T. Felson J.J. Anderson M. Boers et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 1995 727-735
53. D.T. Felson J.J. Anderson M.L. Lange et al. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum 41 1998 1564-1570
54. F. Wolfe T. Pincus J. O'Dell J. Arthritis disease status in clinic: which variables best predict changes in therapy J Rheumatol 28 2001 1712-1717
55. D.M.F.M. Van der Heijde M.A. van't Hof P.L.C.M. van Reil et al. Judging disease activity in clinical practice in rheumatoid arthritis. First step in the development of a 'disease activity score' Ann Rheum Dis 49 1990 916-920
56. M.L.L. Prevoo P.L.C.M. van Riel M.A. van't Hof et al. Validity and reliability of joint counts. A longitudinal study in patients with recent onset arthritis Br J Rheumatol 32 1993 589-594
57. M.L. Prevoo M.A. van't Hof H.H. Kuper et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 1995 44-48
58. J. Fransen P.M.J. Welsing R.M.H. De Keijzer Disease activity scores using C reactive protein: CRP may replace ESR in the assessment of RA disease activity Ann Rheum 62 supplement 1 2003 151
59. A.M. Van Gestel M.L.L. Preevo M.A. Van't Hof et al. Development and validation of the European League against Rheumatism response criteria for rheumatoid arthritis Arthritis Rheum 39 1996 34-40
60. A.M. van Gestel C.J. Haagsma P.L. van Riel Validation of rheumatoid arthritis improvement criteria that include simplified joint counts Arthritis Rheum 41 1998 1845-1850
61. A.M. van Gestel J.J. Anderson P.L. van Riel et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology J Rheumatol 26 1999 705-711
62. J.S. Smolen F.C. Breedveld M.H. Schiff A et al. simplified disease activity index for rheumatoid arthritis for use in clinical practice Rheumatology (Oxford) 42 2003 244-257
63. H.E. Paulus Defining remission in rheumatoid arthritis: What is it? Does it matter? J Rheumatol 31 2004 1-4
64. R.S. Pinals A.T. Masi R.A. Larsen Preliminary criteria for clinical remission in rheumatoid arthritis Arthritis Rheum 24 1981 1308-1315
65. M.L. Prevoo A.M. van Gestel M.A. van't Hof et al. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score Br J Rheumatol 35 1996 1101-1105
66. 28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis J Rheumatol 31 2004 40-46
67. A.K. Brown M.A. Quinn Z. Karim et al. Neither the ACR criteria nor the disease activity score accurately define true remission in rheumatoid arthr itis Arthritis Rheum 46 supplement 2002 S243
68. J.T. Sharp D.Y. Young G.B. Bluhm et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 28 1985 1326-1335
69. D. van der Heijde How to read radiographs according to the Sharp/van der Heijde method J Rheumatol 26 1999 743-745
70. A. Larsen How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies J Rheumatol 22 1995 1974-1975
71. D.L. Scott D.A. Houssien L. Laasonen Proposed modification to Larsen's scoring methods for hand and wrist radiographs Br J Rheumatol 34 1995 56
72. K. Bruynesteyn D. van der Heijde M. Boers et al. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: Preliminary results of a validation study with clinical experts J Rheumatol 28 2001 904-910
73. K. Bruynesteyn D. van der Heijde M. Boers et al. Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference Arthritis Rheum 46 2002 913-920
74. D. van der Heijde T. Dankert F. Nieman et al. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis Rheumatology (Oxford) 38 1999 941-947
75. J.F. Fries P.W. Spitz R.G. Kraines et al. Measurements of patients outcome in arthritis Arthritis Rheum 23 1980 137-145
76. T. Pincus F. Wolfe An infrastructure of patient questionnaires at each rheumatology visit: Improving efficency and documenting care J Rheumatol 27 2000 2727-2730
77. D.P.M. Symmons M.A. Jones D.L. Scott et al. Longterm mortality outcomes in patients with rheumatoid arthritis: Early presenters continue to do well J Rheumatol 25 1998 1072-1077
78. F. Wolfe D.M. Mitchell J.T. Sibley et al. The mortality of rheumatoid arthritis Arthritis Rheum 37 1994 481-494
79. E. Lindqvist K. Eberhardt Mortality in rheumatoid arthritis patients with disease onset in the 1980s Ann Rheum Dis 58 1999 11-14
80. E.J. Kroot M.A. van Leeuwen M.H. van Rijswijk et al. No increased mortality in patients with rheumatoid arthritis: Up to 10 years of follow up from disease onset Ann Rheum Dis 59 2000 954-958
81. T.R. Mikuls K.G. Saag I.A. Criswell et al. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's health study Ann Rheum Dis 61 2002 994-999
82. N.J. Goodson N.J. Wiles M. Lunt et al. Mortality in early inflammatory polyarthritis: Cardiovascular mortality is increased in seropositive patients Arthritis Rheum 46 2002 2010-2019
83. D.H. Solomon E.W. Karlson E.B. Rimm et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 107 2003 1303-1307
84. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115-126
85. V. Pasceri E. Yeh A tale of two diseases: Atherosclerosis and rheumatoid arthritis Circulation 100 1999 2124-2126
86. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363-369
87. J. Danesh J.G. Wheeler G.M Hirschfield et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387-1397
88. N.J. Goodson A.J. Silman M. Lunt Baseline et al. CRP is a major predictor of cardiovascular mortality in inflammatory polyarthritis: results from a population-based interception cohort Arthritis Rheum 48 supplement 2003 S667
89. L.T.H. Jacobsson C. Turesson A. Gülfe et al. Low incidence of first cardiovascular event in rheumatoid arthritis patients treated with TNF-blockers Arthritis Rheum 48 supplement 2003 S241
90. R. Clarke L. Daly K. et al. Robinson Hyperhomocysteinemia: An independent risk factor for vascular disease N Engl J Med 324 1991 1149-1155
91. C.J. Haagsma H.J. Blom P.L. van Riel et al. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis Ann Rheum Dis 8 1999 79-84
92. T.R. Mikuls Co-morbidity in rheumatoid arthritis Best Pract Res Clin Rheumatol 17 2003 729-752
93. Y.B. Park S.K. Lee W.K. Lee et al. Lipid profiles in untreated patients with rheumatoid arthritis J Rheumatol 26 1999 1701-1704
94. M. Boers M.T. Nurmohamed C.J. Doelman et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis Ann Rheum Dis 62 2003 842-845
95. Y. Park H. Choi M. Kim et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: A prospective study Am J Med 113 2002 188-193
96. D.R. Porter C. Grigor A. Stirling et al. A randomised controlled trial of a strategy of tight control of disease activity in rheumatoid arthritis - outcome over 18 months Arthritis Rheum 48 supplement 2003 S232
97. T.A. Pearson S.N. Blair S.R. Daniels et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases Circulation 106 2002 388-391
98. D.W. McCarey N. Sattar R. Hampson et al. A randomized placebo controlled trial comparing the anti-inflammatory and vascular risk modulatory effects of Atorvastatin in rheumatoid arthritis Arthritis Rheum 48 supplement 2003 S666